The Joint Corp. (JYNT)
NASDAQ: JYNT · Real-Time Price · USD
9.06
-0.02 (-0.22%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Company Description

The Joint Corp. operates and is a franchisor and operator of chiropractic clinics in the United States.

The company provides services under the franchise agreement, including training of franchisees and staff, site selection, construction/vendor management and ongoing operations support.

It operates through a network of franchised clinics, offering routine and affordable chiropractic adjustments using a private pay, non-insurance, cash-based model.

The company was incorporated in 2010 and is headquartered in Scottsdale, Arizona.

The Joint Corp.
The Joint logo
Country United States
Founded 2010
IPO Date Nov 11, 2014
Industry Medical Care Facilities
Sector Healthcare
Employees 330
CEO Sanjiv Razdan

Contact Details

Address:
16767 North Perimeter Drive, Suite 110
Scottsdale, Arizona 85260
United States
Phone 480 245 5960
Website thejoint.com

Stock Details

Ticker Symbol JYNT
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001612630
CUSIP Number 47973J102
ISIN Number US47973J1025
Employer ID 90-0544160
SIC Code 6794

Key Executives

Name Position
Sanjiv Razdan Chief Executive Officer, President and Director
Scott Justin Bowman Chief Financial Officer
Ron Stilwell Senior Vice President of Operations and Patient Experience
Charles Nelles Chief Technology Officer
Dr. Steven Knauf Vice President of Chiropractic and Compliance
Andra J. Terrell SVice President, Corporate Secretary and General Counsel,
Debbie L. Gonzalez Chief Marketing Officer
Beth Gross Chief Human Resources Officer
Craig M. Sherwood SVice President and Chief Development Officer
Craig P. Colmar J.D. Secretary

Latest SEC Filings

Date Type Title
Apr 24, 2026 8-K Current Report
Apr 23, 2026 SCHEDULE 13G/A Filing
Apr 7, 2026 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 7, 2026 DEF 14A Other definitive proxy statements
Mar 27, 2026 SCHEDULE 13G/A Filing
Mar 16, 2026 SCHEDULE 13D/A Filing
Mar 13, 2026 10-K Annual Report
Mar 12, 2026 8-K Current Report
Jan 12, 2026 8-K/A [Amend] Current report
Jan 9, 2026 8-K Current Report